Pear
ClosedBoston, United States · Founded 2013 · $234.0M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 51–200
- Founded
- 2013
- Business Model
- B2B
- Total Funding
- $234.0M
- Last Round
- $100.0M Series DDec 2021
- Rounds
- 4
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Pioneer in FDA-cleared prescription digital therapeutics for substance use disorder and mental health.
Summary
Pear is a Biotech company based in Boston, United States, founded in 2013. It has raised $234.0M in total across 4 rounds, most recently a $100.0M Series D round in Dec 2021. Investors include Arboretum Ventures, 5AM Ventures and SoftBank.
Funding History
Dec 2021
Sign up to see all 4 events
Funding: Series A through Series D. Amounts, valuations, and investors where available.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/pear"><img src="https://indexed.vc/api/badge/company/pear" alt="Pear on Indexed.vc" width="260" height="76" /></a>